Cardiovascular disease (CVD) is the leading global cause of death, accounting for 17.3 million deaths per year. Preventive treatment that reduces CVD by even a small percentage can substantially ...

Current American Heart Association recommendations advise secondary prophylaxis for the longer of 5 years or until the age of 21 for those with ARF without carditis, the longer of 10 years or until ...